Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cologne
• Treatments: Contraceptive Agents; Contraceptives, Oral; Goserelin

Criteria

Inclusion Criteria:

• Advanced stage Hodgkins Lymphoma (histologically proven)

• Normal FSH-levels

• Written informed consent

Exclusion Criteria:

• Hodgkins Lymphoma as "composite lymphoma"

• Primary ovarial dysfunction

• Age > 40